Well, markets are going to be very sick, due to Europe debt, fiscal cliff in USA etc....
Some red days are possible.... even for a beast like AFFY.
For newbies, sales went from 2+Mil$ to 9+Mil$ in 2 months!
9+Mil$/month (no more increase in sales, almost impossible)...... 110Mil$/years
50% with takeda--- 55 Mil$/years revenues...... net sales (90% is usual on drug market)... 50Mil$
50Mil$ X multiplier (15 avg for biotech)........ 750Mil$ in Market cap..... where we are today.
Means that 91% of big holders - and the Street - is carefully looking at this stock.
Means that a likely increase in sales is driving this stock very very high.
+/-20 % is part of the game...... but I see AFFY doing like JAZZ..... a sound company with profits.